Rathbones Group PLC Guardant Health, Inc. Transaction History

Rathbones Group PLC

$19 Billion
Q3 2024

A detailed history of Rathbones Group PLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Rathbones Group PLC holds 186,586 shares of GH stock, worth $5.64 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

186,586

Previous 108,395 72.14%

Holding current value

$5.64 Million

Previous $3.13 Million 36.68%

% of portfolio

0.02%

Previous 0.02%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$22.3 - $36.29 $1.74 Million - $2.84 Million	78,191 Added 72.14%	186,586 $4.28 Million
Q2 2024 Aug 09, 2024	BUY	$16.07 - $31.84 $74,998 - $148,597	4,667 Added 4.5%	108,395 $3.13 Million
Q1 2024 May 14, 2024	BUY	$17.13 - $26.91 $137,896 - $216,625	8,050 Added 8.41%	103,728 $2.14 Million
Q4 2023 Feb 13, 2024	SELL	$21.58 - $29.5 $23,867 - $32,627	-1,106 Reduced 1.14%	95,678 $2.59 Million
Q3 2023 Nov 13, 2023	BUY	$25.8 - $39.97 $60,552 - $93,809	2,347 Added 2.49%	96,784 $2.87 Million
Q2 2023 Aug 04, 2023	SELL	$20.94 - $38.01 $20,165 - $36,603	-963 Reduced 1.01%	94,437 $3.38 Million
Q1 2023 May 12, 2023	SELL	$22.92 - $33.76 $71,487 - $105,297	-3,119 Reduced 3.17%	95,400 $2.24 Million
Q4 2022 Feb 14, 2023	SELL	$25.44 - $59.78 $192,402 - $452,116	-7,563 Reduced 7.13%	98,519 $2.68 Million
Q3 2022 Nov 03, 2022	BUY	$43.66 - $61.0 $10,565 - $14,762	242 Added 0.23%	106,082 $5.71 Million
Q2 2022 Aug 12, 2022	SELL	$28.82 - $77.35 $1,469 - $3,944	-51 Reduced 0.05%	105,840 $4.27 Million
Q1 2022 May 11, 2022	SELL	$48.25 - $100.49 $18,672 - $38,889	-387 Reduced 0.36%	105,891 $7.01 Million
Q4 2021 Feb 10, 2022	BUY	$88.71 - $120.43 $999,850 - $1.36 Million	11,271 Added 11.86%	106,278 $10.6 Million
Q3 2021 Nov 04, 2021	BUY	$98.77 - $132.17 $1.69 Million - $2.27 Million	17,156 Added 22.04%	95,007 $11.9 Million
Q2 2021 Jul 30, 2021	BUY	$109.77 - $165.68 $1.83 Million - $2.76 Million	16,633 Added 27.17%	77,851 $9.67 Million
Q1 2021 May 14, 2021	BUY	$127.04 - $179.1 $2.99 Million - $4.21 Million	23,513 Added 62.36%	61,218 $9.35 Million
Q4 2020 Feb 11, 2021	BUY	$99.96 - $135.93 $1.75 Million - $2.37 Million	17,458 Added 86.23%	37,705 $4.86 Million
Q3 2020 Nov 13, 2020	BUY	$80.32 - $111.8 $1.63 Million - $2.26 Million	20,247 New	20,247 $2.26 Million

Others Institutions Holding GH

# of Institutions

321

Shares Held

127M

Call Options Held

651K

Put Options Held

2.35M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.09B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rathbones Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Rathbones Group PLC with notifications on news.

Account

Rathbones Group PLC Guardant Health, Inc. Transaction History